Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis
NCT02537600
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Malignant Melanoma
Interventions
DRUG:
Cobimetinib + Vemurafenib combination treatment
Sponsor
Center Eugene Marquis